公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2005 | Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein | CHIH-HSIN YANG ; Huang C.-J.; Yang C.-S.; Chu Y.-C.; ANN-LII CHENG ; Whang-Peng J.; PAN-CHYR YANG | Cancer Research | 93 | 88 | |
2002 | Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer | CHIH-HSIN YANG ; PAN-CHYR YANG ; Wang L.S.; Lee Y.C.; CHIEN-JEN CHANG ; Lui L.T.; Yen S.H.; CHIUN HSU ; ANN-LII CHENG ; Liu M.Y.; Chiang S.C.; Chen Y.M.; KWEN-TAY LUH ; Huang M.H.; Yang P.-C.; Perng R.-P. | British Journal of Cancer | 24 | 20 | |
2007 | Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; Keng H.-Y.; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Anti-Cancer Drugs | 32 | 29 | |
2008 | Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial | CHIUN HSU ; SUNG-HSIN KUO ; Hu F.-C.; ANN-LII CHENG ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIA-CHI LIN ; Huang T.-C.; PAN-CHYR YANG ; CHIH-HSIN YANG | Lung Cancer | 14 | 11 | |
2009 | Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma | SHIH-HUNG YANG ; ZHONG-ZHE LIN ; SUNG-HSIN KUO ; ANN-LII CHENG | American Journal of Hematology | 1 | 1 | |
2004 | Generation of Carcinoembryonic Antigen (CEA)-Specific T-Cell Responses in HLA-A*0201 and HLA-A*2402 Late-Stage Colorectal Cancer Patients after Vaccination with Dendritic Cells Loaded with CEA Peptides | Liu K.-J.; Wang C.-C.; Chen L.-T.; ANN-LII CHENG ; Lin D.-T.; Wu Y.-C.; Yu W.-L.; Hung Y.-M.; Yang H.-Y.; Juang S.-H.; Whang-Peng J. | Clinical Cancer Research | 80 | 76 | |
2014 | Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma | Liao F.; Hsu Y.-C.; SUNG-HSIN KUO ; Yang Y.-C.; Chen J.-P.; PING-NING HSU ; CHUNG-WU LIN ; Chen L.-T.; ANN-LII CHENG ; Fann C.S.J.; Lin J.-T.; MING-SHIANG WU | Blood Cancer Journal | 23 | 19 | |
2012 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; ANN-LII CHENG ; Hu F.-C.; KUN-HUEI YEH | Gastric Cancer | 19 | 18 | |
2010 | Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG | Contemporary Clinical Trials | 41 | 37 | |
2013 | The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; Chang Y.-L.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Oncology (Switzerland) | 5 | 5 | |
2006 | Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG | Lung Cancer | 35 | 34 | |
2006 | Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa | YEN-SHEN LU ; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG | Journal of Endocrinology | 23 | 21 | |
2015 | Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma | DA-LIANG OU ; Shyue S.-K.; LIANG-IN LIN ; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; CHIUN HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
1995 | Growth of E.coli at low temperature dramatically increases the transformation frequency by electroporation | Chuang S.-E.; ANN-LII CHENG ; Chao C.-C. | Nucleic Acids Research | 20 | 19 | |
2017 | Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study | Hagiwara Y.; Ohashi Y.; Okusaka T.; Ueno H.; Ioka T.; Boku N.; Egawa S.; Hatori T.; Furuse J.; Mizumoto K.; Ohkawa S.; Yamaguchi T.; Yamao K.; Funakoshi A.; ANN-LII CHENG ; Kihara K.; Sato A.; Tanaka M. | ESMO Open | 10 | 40 | |
2021 | Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYnote-240 | Ryoo B.-Y.; Merle P.; Kulkarni A.S.; ANN-LII CHENG ; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Daniele B.; Norquist J.M.; Chen E.; Siegel A.B.; Zhu A.X.; Finn R.S.; Kudo M. | Cancer | 13 | 17 | |
2013 | Helicobacter pylori and mucosa-associated lymphoid tissue: what's new | SUNG-HSIN KUO ; ANN-LII CHENG | Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 45 | 43 | |
2015 | Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; MING-SHIANG WU ; JYH-MING LIOU ; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG | American Journal of Surgical Pathology | 16 | 16 | |
2012 | Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas | SUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; PING-NING HSU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG | Blood | 114 | 93 | |
2014 | Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP | Lin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG ; PING-NING HSU | Cell Death and Disease | 21 | 19 |